{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T04:17:03Z","timestamp":1750306623426,"version":"3.41.0"},"reference-count":7,"publisher":"Galenos Yayinevi","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mirt"],"DOI":"10.4274\/mirt.galenos.2025.94557","type":"journal-article","created":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T11:09:32Z","timestamp":1747998572000},"source":"Crossref","is-referenced-by-count":0,"title":["68Ga-PENTIXAFOR PET\/CT Captures Superscan in Refractory Multiple Myeloma"],"prefix":"10.4274","author":[{"given":"Siven","family":"Kar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harshita","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nusrat","family":"Shaikh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vikram R","family":"Lele","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2811","published-online":{"date-parts":[[2025,5,23]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","first-page":"1","DOI":"10.7150\/thno.5760","article-title":"CXCR4 chemokine receptor overview: biology, pathology and applications in imaging and therapy","volume":"3","author":"Jacobson","year":"2013","unstructured":"1. Jacobson O, Weiss ID. CXCR4 chemokine receptor overview: biology, pathology and applications in imaging and therapy. Theranostics. 2013;3:1-2.","journal-title":"Theranostics"},{"key":"ref1","doi-asserted-by":"publisher","first-page":"5597","DOI":"10.18632\/oncotarget.3343","article-title":"Dysregulated CXCR4 expression promotes lymphoma cell survival and independently predicts disease progression in germinal center B-cell-like diffuse large B-cell lymphoma","volume":"6","author":"Chen","year":"2015","unstructured":"2. Chen J, Xu-Monette ZY, Deng L, Shen Q, Manyam GC, Martinez-Lopez A, Zhang L, Montes-Moreno S, Visco C, Tzankov A, Yin L, Dybkaer K, Chiu A, Orazi A, Zu Y, Bhagat G, Richards KL, Hsi ED, Choi WW, van Krieken JH, Huh J, Ponzoni M, Ferreri AJ, Zhao X, M\u00f8ller MB, Farnen JP, Winter JN, Piris MA, Pham L, Young KH. Dysregulated CXCR4 expression promotes lymphoma cell survival and independently predicts disease progression in germinal center B-cell-like diffuse large B-cell lymphoma. Oncotarget. 2015;6:5597-614.","journal-title":"Oncotarget"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"20211272","DOI":"10.1259\/bjr.20211272","article-title":"Imaging CXCR4 receptors expression for staging multiple myeloma by using 68Ga-Pentixafor PET\/CT: comparison with 18F-FDG PET\/CT","volume":"95","author":"Shekhawat","year":"2022","unstructured":"3. Shekhawat AS, Singh B, Malhotra P, Watts A, Basher R, Kaur H, Hooda M, Radotra BD. Imaging CXCR4 receptors expression for staging multiple myeloma by using 68Ga-Pentixafor PET\/CT: comparison with 18F-FDG PET\/CT. Br J Radiol. 2022;95:20211272.","journal-title":"Br J Radiol"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"96","DOI":"10.2967\/jnumed.121.262206","article-title":"68Ga-Pentixafor PET\/CT for Detection of Chemokine Receptor CXCR4 Expression in Myeloproliferative Neoplasms","volume":"63","author":"Kraus","year":"2022","unstructured":"4. Kraus S, Dierks A, Rasche L, Kertels O, Kircher M, Schirbel A, Zovko J, Steinbrunn T, Tibes R, Wester HJ, Buck AK, Einsele H, Kort\u00fcm KM, Rosenwald A, Lapa C. 68Ga-Pentixafor PET\/CT for Detection of Chemokine Receptor CXCR4 Expression in Myeloproliferative Neoplasms. J Nucl Med. 2022;63:96-99.","journal-title":"J Nucl Med"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"5. Hu J, Xu T, Shen H, Song Y, Yang J, Zhang A, Ding H, Xing N, Li Z, Qiu L, Ma L, Yang Y, Feng Z, Du Z, He W, Sun Y, Cai J, Li Q, Chen Y, Yang S. Chongqing Primary Aldosteronism Study (CONPASS) Group. Accuracy of Gallium-68 Pentixafor Positron Emission Tomography-Computed Tomography for Subtyping Diagnosis of Primary Aldosteronism. JAMA Netw Open. 2023;6:e2255609.","DOI":"10.1001\/jamanetworkopen.2022.55609"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"1926","DOI":"10.1007\/s00259-024-06621-0","article-title":"[68Ga]Pentixafor PET\/CT for staging and prognostic assessment of newly diagnosed multiple myeloma: comparison to [18F]FDG PET\/CT","volume":"51","author":"Chen","year":"2024","unstructured":"6. Chen Z, Yang A, Chen A, Dong J, Lin J, Huang C, Zhang J, Liu H, Zeng Z, Miao W. [68Ga]Pentixafor PET\/CT for staging and prognostic assessment of newly diagnosed multiple myeloma: comparison to [18F]FDG PET\/CT. Eur J Nucl Med Mol Imaging. 2024;51:1926-1936.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1097\/RLU.0000000000002404","article-title":"Skeletal Superscan on 18F-FDG PET\/CT in a Patient With Multiple Myeloma","volume":"44","author":"Fu","year":"2019","unstructured":"7. Fu Z, Chen X, Yang X, Li Q. Skeletal Superscan on 18F-FDG PET\/CT in a Patient With Multiple Myeloma. Clin Nucl Med. 2019;44:169-170.","journal-title":"Clin Nucl Med"}],"container-title":["Molecular Imaging and Radionuclide Therapy"],"original-title":[],"deposited":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T06:44:39Z","timestamp":1750229079000},"score":1,"resource":{"primary":{"URL":"https:\/\/mirt.tsnmjournals.org\/articles\/lesssupgreater68lesssupgreaterga-pentixafor-petct-captures-superscan-in-refractory-multiple-myeloma\/doi\/mirt.galenos.2025.94557"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,23]]},"references-count":7,"URL":"https:\/\/doi.org\/10.4274\/mirt.galenos.2025.94557","relation":{},"ISSN":["2146-1414","2147-1959"],"issn-type":[{"type":"print","value":"2146-1414"},{"type":"electronic","value":"2147-1959"}],"subject":[],"published":{"date-parts":[[2025,5,23]]}}}